A Longitudinal Study of Familial Hypereosinophilia (FE): Natural History and Markers of Disease Progression

Recruiting Observational Study
Eosinophilia Hypereosinophilic Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 – 100
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID) · NIH
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Eosinophils are a type of white blood cell. Elevated eosinophil levels can damage the heart, nerves, and other organs, in the syndrome known as hypereosinophilic syndrome (HES). Some individuals have a hereditary form of HES known as familial eosinophilia (FE). More research on the causation and mechanisms of HES is needed in order to design more effective and less toxic therapies. This study wil…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Stated willingness to comply with all study procedures and availability for the duration of the study * Male or female, aged 1-100 years of age * Genetically related…
Contacts

Thomas W Brown, R.N.

(301) 402-7823

browntw@mail.nih.gov

CONTACT

Amy D Klion, M.D.

(240) 381-6073

amy.klion@nih.gov

CONTACT